Riskpilot← Back to searchSign inGet full accessARETHUSA AS
ASActiveOrg 950527420Holmegild Gård, 1798 AremarkWholesale of pharmaceutical and medical goods · NACE 4646Est. 19890 employees
Revenue 2024
NOK 24K
-78% vs 2023
EBITDA margin
-2167.2%
-65% vs 2023
Equity ratio
93.9%
Financial strength
Net profit 2024
NOK 21,8M
+289% vs 2023
| Revenue | NOK 24K | -78% |
| EBITDA | NOK -531K | -65% |
| Net profit | NOK 21,8M | +289% |
| Total assets | NOK 283,3M | +0% |
| Equity | NOK 266,1M | +2% |
| Employees | 0 | — |
Legal name
ARETHUSA AS
Org number
950527420
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2. januar 1989
Share capital
NOK 155 266
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Holmegild Gård, 1798 Aremark
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 62 | 63 | 70 | 60 | 84 | 70 | 93 | 102 | 105 | 112 | 24 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −244 | −163 | −125 | −357 | −192 | −665 | −491 | −126 | −494 | −322 | −531 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −124 | −124 | −124 | −124 | −124 | −124 | −124 | −124 | −124 | −124 | −124 |
| EBIT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −368 | −286 | −248 | −480 | −316 | −789 | −614 | −249 | −618 | −446 | −654 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 930 | 3 377 | 4 467 | 9 365 | 6 041 | 10 244 | 32 412 | 18 649 | 18 540 | 6 772 | 24 202 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 562 | 3 090 | 4 219 | 8 884 | 5 725 | 9 455 | 31 798 | 18 400 | 17 922 | 6 326 | 23 548 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | 1 605 | −0 | 121 | 87 | 79 | 343 | 139 | 178 | 202 | 710 | 1 717 |
| Net profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 957 | 3 090 | 4 098 | 8 797 | 5 646 | 9 112 | 31 658 | 18 222 | 17 721 | 5 616 | 21 831 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | — | — | — | — | — | — | 135 718 | 137 172 | 138 385 | 146 157 | 152 796 | 244 078 | 268 926 | 276 605 | 288 215 | 283 785 | 283 322 |
| Equity | — | — | — | — | — | — | — | 134 063 | 134 153 | 137 251 | 145 048 | 150 694 | 237 114 | 261 167 | 269 054 | 277 458 | 259 758 | 266 063 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42 | 1 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 655 | 3 019 | 1 135 | 1 110 | 2 102 | 6 965 | 7 759 | 7 510 | 10 756 | 24 027 | 17 259 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 655 | 3 019 | 1 135 | 1 110 | 2 102 | 6 965 | 7 759 | 7 551 | 10 757 | 24 027 | 17 259 |
EBITDA margin
-2167.2%
This company
15.8%
Market median
-13816% vs market
20072024
Equity ratio
93.9%
This company
38.2%
Market median
+146% vs market
20072024
Return on equity
8.2%
This company
18.4%
Market median
-55% vs market
20072024
Net profit margin
89158.2%
This company
8.1%
Market median
+1100619% vs market
20072024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20072024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20072024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HA Deputy Member | Deputy Member | 2004 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Grandiflora Invest As | Company | 22.5% | 22.5% | 2024 |
Crespo As | Company | 22.5% | 22.5% | 2024 |
Barko As | Company | 19.9% | 19.9% | 2024 |
| Individual | 9.7% | 9.7% | 2024 | |
| Individual | 8.5% | 8.5% | 2024 | |
| Individual | 8.5% | 8.5% | 2024 | |
| Individual | 8.5% | 8.5% | 2024 | |
| Individual | 8.5% | 8.5% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ARETHUSA AS 
ANAXO FORVALTNING ASBoard members of ARETHUSA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hilde Anker-Rasch | Deputy Member | 0 companies |